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systemic resistance are used, although some recommend
isoprenaline, as it reduces the cardiac size and diminishes the
effective degree of tamponade while increasing cardiac
output.2 The definitive treatment of cardiac tamponade is the
removal of cardiac diastolic restriction by either
pericardiocentesis or thoracotomy. Pericardiocnetesis is
usually performed for urgent management of an acute
tamponade (the acute removal of as little as 50 ml of fluid is
often sufficient to correct the hypotension). A thoracotomy is
often required when a tamponade exists following coronary
artery bypass grafting, penetrating or closed cardiac trauma
and aortic dissection. It is also indicated when
pericardiocentesis has failed to relieve the tamponade.
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Conclusion
Cardiac tamponade is a life-threatening emergency.
Immediate recognition and treatment are imperative if a
disastrous outcome is to be prevented.
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Abstract
Ovarian squamous cell carcinoma is a rare
malignancy and the occurrence is attributable to malignant
transformation of an existing ovarian dermoid cyst. The de
novo occurrence of squamous cell carcinoma of the ovary,
in the absence of an antecedent ovarian dermoid, is
extremely rare. The case of a 31 year old Asian woman,
evaluated for abdominal distension and discomfort is
presented. Abdominal CT was suggestive of a malignant
neoplastic process. Laparotomy confirmed a malignant
tumour with involvement of the right adnexa and extension
into the omentum and bowel. Surgical debulking,
hysterectomy, bilateral salpingo-ophorectomy and total
omentectomy and bowel resection was performed.
Histopathology demonstrated squamous cell carcinoma
arising from the right ovary with no co-existing ovarian
dermoid. The postoperative period was significant for
disease progression despite adjuvant chemotherapy.

Introduction
Squamous cell carcinoma of the ovary is a rare
clinical entity, accounting for less than 1% of all malignant
tumours of the ovary.1 Malignant transformation of a pre-
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existing mature cystic teratoma (dermoid cyst) is
appreciated as the underlying pathophysiological
mechanism, and this phenomenon is considered rare, as
only 1-2% of teratomas demonstrate this change.1 The de
novo development of a primary squamous carcinoma, in an
otherwise healthy ovary is an extremely rare occurrence.2-5
We present a case of this rare malignancy, not been
previously reported in the Southeast Asian population, with
a review of literature.

Case Report
A 31 year old, para 2, Asian female (Pakistani
heritage) was referred to the general surgery clinic with a
one year history of progressive abdominal discomfort and
distension. She had a history of weight loss with no change
in appetite, bowel habit or menstrual flow. A recent pap
smear was negative for dysplasia. On examination, she was
anaemic with no jaundice, lymphadenopathy and had
normal breast examination. Abdominal examination
revealed a firm, mildly tender, mobile mass occupying most
of the lower abdomen. There was no clinical evidence of
ascites. Pelvic and rectal exams were unremarkable.
Pre-operative evaluation showed anaemia with
normal cell counts, and normal kidney and liver functions.
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free. The cervix, uterus, fallopian tubes and the left ovary
were histologically unremarkable; the clinical staging for
ovarian tumour was thus consistent with FIGO stage IIIC.
Despite initiation of adjuvant chemotherapy with
cisplatin and etoposide, over the course of the next three
months, there was clinical and radiographic evidence of
tumour progression with metastases to the liver, mesenteric
and pelvic lymph nodes.

Discussion

Figure 1. Contrast-enhanced CT scan of the pelvis showing the tumour mass.

An abdominal and pelvic CT scan with contrast
demonstrated a heterogenous mass (5.5 x 10 x 13 cm)
occupying the lower abdomen appearing to arise from the
bowel mesentery (Figure 1).
The patient presented to the emergency room with
increased abdominal pain and fever before the planned
elective surgery and an exploratory laparotomy was
performed. Intra-operative features suggested peritonitis
with contamination by large bowel contents. On
exploration, the solid mass was seen to be arising from the
right adnexal area. An area of the sigmoid colon was noted
to have a perforation where it was adherent to the mass.
There was evidence of peritoneal metastatic disease with
omental involvement and deposits on the small bowel
mesentery. An intra-operative frozen section on one of the
tumour deposits suggested a malignant tumour of squamous
origin.
Surgical removal of all grossly visible tumour was
undertaken, including performance of a total abdominal
hysterectomy and bilateral salpingo-oophorectomy, sigmoid
colectomy with primary closure of the rectal stump and
exteriorization of the proximal bowel as a mucus fistula.
Total omentectomy and limited small bowel resection with
an end ileostomy was also performed. The immediate
postoperative course was remarkable for abdominal wound
infection requiring periodic debridement and antibiotics.
The histopathology confirmed a well differentiated
squamous cell carcinoma arising from the right ovary, with
evidence of keratinisation. The pathology was remarkable
for an absence of any normal ovarian parenchyma, a
concomitant teratoma or features suggestive of
endometriosis. The histopathological features of the
retroperitoneal tumour deposits and the resected ileum were
identical to that of the resected adnexa. All the resection
margins and the three recovered lymph nodes were tumour
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Ovarian cancer remains the second most common
female genital tract malignancy. Mature cystic teratomas,
commonly known as dermoids, represent over 10% of the
ovarian tumours.1 On rare occasions (1-2%) the dermoids
provide a background for malignant transformation within
components of the teratoma; the majority of such
malignancies arising within an ovarian dermoid (80-90%)
are squamous cell carcinomas.1 Malignant transformations
have also been reported in endometriotic ovaries.3,6 Reports
of primary squamous cell carcinomas arising in otherwise
healthy ovaries are markedly rare2-5; such an occurrence has
not previously been described in a patient of Southeast
Asian heritage.
In contrast to the described presentation, carcinomas
reported to arise within a background of an ovarian dermoid
are likely to be an incidental histological finding. A few
predictive risk factors associated with such malignancy are
recognized, namely advancing age, tumour size (higher
likelihood appreciated with larger tumour sizes),
radiographic characteristics and tumour markers (CA125).1
Of the reported cases of pure squamous cell
carcinoma of the ovary in the literature, the majority were
associated with cervical dysplasia.3,7 Such an association
however was not apparent in our case as demonstrated by a
negative pre-operative pap smear and confirmed by post
operative surgical pathology.
Due to the rarity of the condition, as well as an
incidental nature of the diagnosis, the optimal management
approach to primary ovarian squamous cell carcinomas
remains unclear. Reported literature suggests that the
surgical management for the described cases is akin to that
for adenocarcinomas of the ovary, entailing performance of
total abdominal hysterectomy, bilateral salpingooophorectomy and omentectomy, with additional steps as
needed to ensure surgical debulking of all grossly visible
disease. Indeed, optimal cytoreduction and the surgical
stage at presentation has been correlated with a significantly
improved survival for squamous cell carcinomas arising
from dermoid cysts.8 While a grossly optimal surgical
debulking was achieved at the primary surgery, the existing
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peritoneal contamination is likely to have contributed to a
failure to achieve optimal cytoreduction in the case
presented.
The role of adjuvant therapy in the management of
ovarian squamous cell carcinomas is similarly unclear.
Limited experience suggests that surgical management with
close follow up alone would suffice for early stage 1A
disease.7 Stages 1C and above have been targeted with a
variety of adjuvant regimens with variable outcomes.
Relatively poor disease control has been noted with the
conventional regimens to treat epithelial ovarian cancers, i.e
cisplatin, vincristine, mitomycin C, and bleomycin
(POMB).9 On the other hand remarkable responses have
been achieved with paclitaxel based regimens in some
cases.9,10
Radiotherapy has also been used with the rationale
of squamous cell carcinoma being a radiosensitive tumour;
and has brought forth variable results for cancers within
antecedent dermoids.1,8 In the latest case series and review
of literature1, albeit in cases of squamous cell cancers
arising in mature cystic teratoma of the ovary, whole-pelvis
radiation and concurrent weekly platinum-based
chemotherapy following aggressive cytoreduction has been
shown to be of benefit. It however remains unclear whether
patients with de novo primary squamous cell cancer of the
ovary would benefit as much from similar adjuvant therapy.
To conclude primary squamous cell cancers arising
in the ovary is an extremely rare entity, and has not
previously been described in patients of Southeast Asian
heritage. In the absence of well designed trials, and based on
the existing albeit sparse data, the primary management

approach at present is surgical debulking, akin to the
principles underlying the management of ovarian
adenocarcinoma. Combination chemotherapy with newer
drugs has shown some benefit and pelvic radiotherapy may
have a role to play for local control. However, in the
absence of quality data, except for the very early stages of
presentation, a role for adjuvant therapy is at present
unclear.
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Case Report
Primary Cutaneous B Cell Lymphoma- Leg Type
(NEW EORTC - WHO Classification), with nasal sinuses involvement
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Abstract
Primary Cutaneous lymphomas of B cell origin are
rare, there remains a controversy in truly classifying these
lymphomas and an updated EORTC classification divides
them on the basis of their distinct histopthological grounds
rather than on the basis of their anatomic location as in WHO
classification, while the new WHO- EORTC joint
classification maintains some characteristics of both systems,
We report an elderly gentleman who primarily had a typical
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Leg dominant Cutaneous lymphoma of B cell origin
uniquely with involvement of nasal Sinusues , bearing the
Immunohistochemical staining features of " Cutaneous
lymphoma - Leg Type" befitting the new joint WHO-EORTC
classification of Cutaneous B cell Lymphoma.

Introduction
Cutaneous lymphomas are uncommon skin tumours,
with skin being either the primary site for the origin of the
tumour or more often the secondary site. Approximately
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